R1 RCM Inc RCM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RCM is a good fit for your portfolio.
News
-
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
-
R1 RCM Forms Special Committee to Evaluate Strategic Alternatives
-
R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
-
R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
-
R1 RCM Reports Fourth Quarter and Full Year 2023 Results
-
R1 RCM to Present at Upcoming Investor Conferences
-
R1 Wins Multiple Best in KLAS Awards for Third Straight Year
-
R1 RCM Completes Acquisition of Acclara, Providence’s Modular Services Business
Trading Information
- Previous Close Price
- $12.99
- Day Range
- $12.92–13.30
- 52-Week Range
- $8.87–18.70
- Bid/Ask
- $12.93 / $12.94
- Market Cap
- $5.43 Bil
- Volume/Avg
- 2.1 Mil / 4.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 55.81
- Price/Sales
- 2.62
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.49%
Company Profile
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 30,000
- Website
- https://www.r1rcm.com
Comparables
Valuation
Metric
|
RCM
|
PRVA
|
TRHC
|
---|---|---|---|
Price/Earnings (Normalized) | 55.81 | 29.70 | — |
Price/Book Value | 1.99 | 4.12 | — |
Price/Sales | 2.62 | 1.47 | 0.78 |
Price/Cash Flow | 14.31 | 33.80 | — |
Price/Earnings
RCM
PRVA
TRHC
Financial Strength
Metric
|
RCM
|
PRVA
|
TRHC
|
---|---|---|---|
Quick Ratio | 1.60 | 1.76 | 1.28 |
Current Ratio | 1.83 | 1.81 | 1.57 |
Interest Coverage | 1.17 | — | −8.04 |
Quick Ratio
RCM
PRVA
TRHC
Profitability
Metric
|
RCM
|
PRVA
|
TRHC
|
---|---|---|---|
Return on Assets (Normalized) | 2.70% | 8.86% | −2.75% |
Return on Equity (Normalized) | 5.00% | 15.41% | — |
Return on Invested Capital (Normalized) | 5.18% | 13.03% | −1.87% |
Return on Assets
RCM
PRVA
TRHC
Health Information Services Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Dnzgt | $41.1 Bil | |
VEEV
| Veeva Systems Inc Class A | Wsgxqzhp | Czcm | $37.6 Bil | |
MTHRF
| M3 Inc | — | Wrpgy | $9.6 Bil | |
MTHRY
| M3 Inc ADR | — | Kmpckm | $9.6 Bil | |
PMCUF
| Pro Medicus Ltd | — | Hrrtpf | $7.0 Bil | |
HQY
| HealthEquity Inc | — | Qpthch | $6.9 Bil | |
DOCS
| Doximity Inc Class A | — | Lgqnh | $5.0 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Mrd | $4.4 Bil | |
EVH
| Evolent Health Inc Class A | — | Lly | $3.7 Bil |